NexImmune Raises Gross Proceeds of $126.5M in Upsized IPO Legacy SPIVs Establish Rapha Capital's Expertise in Identifying Disruptive Technologies MIAMI, Feb....
Read More
GAITHERSBURG, Md., Feb. 11, 2021 (GLOBE NEWSWIRE) -- NexImmune, Inc., a clinical-stage biotechnology company developing a novel approach to immunotherapy...
Read More
MIAMI, Feb. 8, 2021 /PRNewswire/ — Ponce Therapeutics, Inc. (“Ponce”), a company leveraging the growing scientific knowledge surrounding the aging process to…
